...
首页> 外文期刊>Cytometry, Part A: the journal of the International Society for Analytical Cytology >Next-generation amplicon TRB locus sequencing can overcome limitations of flow-cytometric V beta expression analysis and confirms clonality in all T-cell prolymphocytic leukemia cases
【24h】

Next-generation amplicon TRB locus sequencing can overcome limitations of flow-cytometric V beta expression analysis and confirms clonality in all T-cell prolymphocytic leukemia cases

机译:下一代扩增子TRB基因座测序可以克服流动细胞仪Vβ表达分析的限制,并确认所有T细胞Plosmphocytic白血病病例中的克隆性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

T-cell receptor (TCR) beta repertoire analysis can distinguish monoclonal from polyclonal T-cell proliferations and crucially aid in the diagnosis of T-cell malignancies. TCR repertoire can be assessed either by flow cytometry (FCM), or by molecular genetic techniques. We compared the results of parallel analyses of V beta expression by FCM and TRB rearrangements by DNA-based next-generation sequencing (NGS) in 80 diagnostic peripheral blood samples of patients with T-cell prolymphocytic leukemia (T-PLL) for (1) the diagnosis of clonality and (2) the assessment of dominant V beta usage. FCM-based analysis of the surface expression was performed using the IOTest Beta Mark kit. The NGS-based analysis employed the multiplex Biomed-2 VB-JB primers. In all the samples, one or two clonal TRB rearrangements were detected by NGS. Although a dominant V beta domain usage was detected by FCM in only 41/80 (51%) samples, clonality was suspected in all of them. In a total of 12 cases, the FCM missed the clone detected by NGS, despite theoretical coverage by the antibodies, the functionality of the rearrangement, and the expression of TCR alpha beta on the cell surface. Partly overlapping with those cases, FCM discovered predominant V beta usage in the T-PLL population that differed from the one detected by NGS in 10 cases. Overall, the concordant NGS and FCM results were obtained on 61/80 (76%) of samples. We conclude that NGS-based TRB analysis can overcome certain limitations of FCM-based analysis by the identification of both productive and nonproductive rearrangements and by covering the whole V beta spectrum. Currently available FCM analysis of V beta expression lacks this breadth but has advantages, such as parallel immunophenotyping and a more accurate quantification of the V beta usage. (c) 2018 International Society for Advancement of Cytometry
机译:T细胞受体(TCR)β重组分析可以区分单克隆从多克隆T细胞增殖中的单克隆,并且在诊断T细胞恶性肿瘤的诊断中。可以通过流式细胞术(FCM)或通过分子遗传技术来评估TCR ReptoIre。将FCM的下一代测序(NGS)与T细胞Propymyytic白血病(T-PLL)患者的DNA的下一代测序(NGS)进行了基于DNA的下一代测序(NGS)的FCM和TRB重排并行分析的结果。(1)的患者的80例诊断外周血样品克隆品的诊断和(2)占主导地位的Vβ用法的评估。使用IOTESTβ标记试剂盒进行基于FCM的表面表达分析。基于NGS的分析采用多路复用生物密 - 2 VB-JB引物。在所有样品中,NGS检测一个或两个克隆TRB重排。虽然FCM仅在41/80(51%)样本中检测到优势Vβ域使用,但在所有这些中都怀疑克隆性。总共12例,FCM错过了NGS检测到的克隆,尽管抗体的理论覆盖,重排的功能,以及TCRαβ对细胞表面的表达。与这些情况部分重叠,FCM在T-PLL群体中发现了与NGS检测到的10例不同的PLL群体中的主要vβ使用。总体而言,在61/80(76%)样品中获得了一致性NGS和FCM结果。我们得出结论,基于NGS的TRB分析可以通过鉴定生产性和非生产性重排和通过覆盖整个Vβ光谱来克服基于FCM的分析的某些限制。目前可用的Vβ表达的FCM分析缺乏此宽度但具有不同的优点,如平行免疫蛋白型和更准确的Vβ使用量化。 (c)2018国际促进细胞计量学会

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号